Vivimed Labs Limited (VIVIMEDLAB) — corporate announcements

All
Important
Financial Update
Fund Raise
Board Meeting
Dividend/Bonus
JV/Acquisition
Investor Meet
Insider Trade
Pledging
Others

Download our app

Get the best experience on mobile

Join 5K+ users on Alpha Tribe

Vivimed Labs Limited

$VIVIMEDLAB

Vivimed Labs Ltd is primarily engaged in the business of APIs, CDMO, Finished Dosage Formulation, Specialty Chemicals and retail branded formulation manufacturing.

Pharmaceuticals

17-08-2026 | 04:56 pm

Vivimed Labs Limited has informed the Exchange about Corporate Insolvency Resolution Process

PDF

22-07-2026 | 05:14 pm

Vivimed's share transfer agent reported no re-lodgement requests for physical shares in June. Zero requests were received, processed, approved, or rejected, indicating no operational activity in physical share transfers.

PDF

22-07-2026 | 05:12 pm

Vivimed Labs has published financial results for the quarter and year ended March 31, 2026. These results were approved by the Board of Directors. Full details are available on stock exchange and company websites.

PDF

10-07-2026 | 03:48 pm

Vivimed Labs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

PDF

30-06-2026 | 03:23 pm

Vivimed Labs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

PDF

Download our app

Vivimed Labs Limited

Vivimed Labs Limited

Corporate Insolvency Resolution Process

Vivimed Labs Limited

Updates

Vivimed Labs Limited

General Updates

Vivimed Labs Limited

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Vivimed Labs Limited

Trading Window